{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:01:20Z","timestamp":1762671680338,"version":"3.30.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1995,11,1]],"date-time":"1995-11-01T00:00:00Z","timestamp":815184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[1995,11]]},"DOI":"10.1007\/bf00302075","type":"journal-article","created":{"date-parts":[[2004,10,9]],"date-time":"2004-10-09T23:48:30Z","timestamp":1097365710000},"page":"385-391","source":"Crossref","is-referenced-by-count":10,"title":["Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats"],"prefix":"10.1007","volume":"57","author":[{"given":"G.","family":"Jablonski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. M.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. H.","family":"Klem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mosekilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. C.","family":"Danielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. O.","family":"Gordeladze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"5","key":"CR1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01137964","volume":"13","author":"G Jablonski","year":"1993","unstructured":"Jablonski G, Klem KH, Attamadal A, Dahl E, R\u00f8nningen H, Gautvik KM, Haug E, Gordeladze JO (1993) Surgically induced uremia in rats 1: effect on bone strength and metabolism. Biosci Rep 13(5):275?287","journal-title":"Biosci Rep"},{"issue":"4","key":"CR2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0030-5898(20)31263-3","volume":"15","author":"KL Klein","year":"1984","unstructured":"Klein KL, Maxwell MH (1984) Renal osteodystrophy. Orthop Clin North Am 15(4):687?695","journal-title":"Orthop Clin North Am"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.me.43.020192.001303","volume":"43","author":"WG Goodman","year":"1992","unstructured":"Goodman WG, Coburn JW (1992) The use of 1,25-dihydroxyvitamin D3 in early renal failure. Annu Rev Med 43:227?237","journal-title":"Annu Rev Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0167-4889(90)90101-I","volume":"1054","author":"KH Klem","year":"1990","unstructured":"Klem KH, Jablonski G, S\u00e6ther O, Jarosz G, Gautvik KM, Gordeladze JO (1990) 1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH)-sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action. Biochim Biophys Acta 1054:304?310","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/8756-3282(92)90453-4","volume":"13","author":"MM Popovtzer","year":"1992","unstructured":"Popovtzer MM, Levi J, Bar-Khayim Y, Shasha SM, Boner G, Bernheim J, Chaimovitz C, Rubinger D, Gafter U, Gazit D, et al. (1992) Assessment of combined 24,25(OH)2D3 and 1?(OH)D3 therapy for bone disease in dialysis patients. Bone 13(5):369?377","journal-title":"Bone"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00298729","volume":"52","author":"H Yamato","year":"1993","unstructured":"Yamato H, Okazaki R, Ishii T, Ogata E, Sato T, Kumegawa M, Akaogi K, Taniguchi N, Matsumoto T (1993) Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells. Calcif Tissue Int 52:255?260","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"CR7","first-page":"1011","volume":"51","author":"T Shoji","year":"1993","unstructured":"Shoji T, Maruno F (1993) Renal osteodystrophy. Nippon Rinsho 51(4):1011?1016","journal-title":"Nippon Rinsho"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","volume":"83","author":"JA Delmez","year":"1989","unstructured":"Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E (1989) Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. J Clin Invest 83:1349?1355","journal-title":"J Clin Invest"},{"issue":"(suppl)1","key":"CR9","first-page":"S87","volume":"38","author":"HH Malluche","year":"1992","unstructured":"Malluche HH (1992) The possible use of biphosphonates in the treatment of renal osteodystrophy. Clin Nephrol 38 (suppl)1:S87-S91","journal-title":"Clin Nephrol"},{"key":"CR10","first-page":"725","volume":"49","author":"M Ishida","year":"1991","unstructured":"Ishida M, Yamada M (1991) Calcitonin for therapy of renal osteodystrophy due to long-term hemodialysis in patients with chronic kidney failure. Nippon Rinsho 49 (suppl):725?731","journal-title":"Nippon Rinsho"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0009-8981(88)90203-3","volume":"176","author":"H Oftebro","year":"1988","unstructured":"Oftebro H, Falch JA, Holmberg I, Haug E (1988) Validation of radioreceptor assay for 1,25-dihydroxyvitamin D using selected ion monitoring GC-MS. Clin Chim Acta 176:157?168","journal-title":"Clin Chim Acta"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/00365517909106133","volume":"39","author":"KM Gautvik","year":"1979","unstructured":"Gautvik KM, Toig V, Halvorsen JF, Arnesen E, Myhre L, Heimann P, Tollman R (1979) Development of sequence-specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparathyroidism. Scand J Clin Lab Invest 39:469?478","journal-title":"Scand J Clin Lab Invest"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0006-2944(78)90046-7","volume":"20","author":"JO Gordeladze","year":"1978","unstructured":"Gordeladze JO, Halse J, Dj\u00f8seland O, Haugen HN (1978) A simple procedure for the determination of hydroxyproline in urine and bone. Biochem Med 20:23?30","journal-title":"Biochem Med"},{"issue":"6","key":"CR14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0006-2952(86)90074-2","volume":"35","author":"JO Gordeladze","year":"1986","unstructured":"Gordeladze JO, Gautvik KM (1986) Hydroxycholecalciferols modulate parathyroid hormone and calcitonin-sensitive adenylyl cyclase in bone and kidney of rats. A possible physiological role for 24,25-dihydroxy vitamin D3. Biochem Pharmacol 35(6):899?902","journal-title":"Biochem Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1016\/S0021-9258(19)89202-5","volume":"261","author":"S Jackowski","year":"1986","unstructured":"Jackowski S, Rettenmier CW, Sherr CJ, Rock CO (1986) A guanine nucleotide-dependent phosphatidylinositol 4,5-diphosphate phospholipase C in cells transformed by the v-fms and v-fes oncogenes. J Biol Chem 261:4978?4985","journal-title":"J Biol Chem"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3109\/17453677808993231","volume":"49","author":"LB Enges\u00e6ter","year":"1978","unstructured":"Enges\u00e6ter LB, Ekeland A, Langeland N (1978) Methods for testing the mechanical properties of the rat femun. Acta Orthop Scand 49:512?518","journal-title":"Acta Orthop Scand"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00298796","volume":"50","author":"CC Danielsen","year":"1992","unstructured":"Danielsen CC, Mosekilde Li, Andreassen TT (1992) Long-term effect of orchidectomy on cortical bone from rat femur: bone mass and mechanical properties. Calcif Tissue Int 50:169?174","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF00675623","volume":"52","author":"CC Danielsen","year":"1993","unstructured":"Danielsen CC, Mosekilde Li, Svenstrup B (1993) Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution. Calcif Tissue Int 52(1):26?33","journal-title":"Calcif Tissue Int"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jbmr.5650030402","volume":"3","author":"E Dahl","year":"1988","unstructured":"Dahl E, Nordal KP, Halse J, Attamadal A (1988) Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects. Bone Miner 3:369?377","journal-title":"Bone Miner"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/8756-3282(93)90251-5","volume":"14","author":"Li Mosekilde","year":"1993","unstructured":"Mosekilde Li, Bak B (1993) The effects of growth hormone on fracture healing in rats: a histological description. Bone 14:19?27","journal-title":"Bone"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595?610","journal-title":"J Bone Miner Res"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/8756-3282(90)90079-E","volume":"11","author":"WG Lieuallen","year":"1990","unstructured":"Lieuallen WG, Wiesbrode SE, Horst RL (1990) The effects of the major vitamin D metabolites upon the resolution of osteomalacia in uremic adults rats. Bone 11:267?273","journal-title":"Bone"},{"issue":"6","key":"CR23","first-page":"358","volume":"11","author":"CR Dunstan","year":"1985","unstructured":"Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Johnson JR, George CR, Collett P et al (1985) Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. Miner Electrolyte Metab 11(6):358?368","journal-title":"Miner Electrolyte Metab"},{"issue":"2","key":"CR24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/8756-3282(85)90315-1","volume":"6","author":"I Atkin","year":"1985","unstructured":"Atkin I, Pita JC, Ornoy A, Agundez A, Castiglione G, Howell DS (1985) Effects of vitamin D metabolites on healing of low phosphate, vitamin D-deficient induced rickets in rats. Bone 6(2):113?123","journal-title":"Bone"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0026-0495(82)90162-7","volume":"31","author":"JE Harrison","year":"1982","unstructured":"Harrison JE, Hitchman AJ, Jones G, Tam CS, Heersche JN (1982) Plasma vitamin D metabolite levels in phosphorusdeficient rats during the development of vitamin D-deficient rickets. Metabolism 31:1121?1127","journal-title":"Metabolism"},{"key":"CR26","first-page":"152","volume":"94","author":"SG Massry","year":"1979","unstructured":"Massry SG, Tuma S, Dua S, Goldstein DA (1979) Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3. J Lab Clin Med 94:152?157","journal-title":"J Lab Clin Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","volume":"321","author":"DL Andress","year":"1989","unstructured":"Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ (1989) Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274?279","journal-title":"N Engl J Med"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/jcem-46-2-284","volume":"46","author":"P Bordier","year":"1978","unstructured":"Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A (1978) Vitamin D metabolite and bone mineralization in man. J Clin Endocrinol Metab 46:284?294","journal-title":"J Clin Endocrinol Metab"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1111\/j.1365-2265.1977.tb03370.x","volume":"7","author":"AM Pierides","year":"1977","unstructured":"Pierides AM, Ellis HA, Simpson W, Cook D, Kerr DN (1977) The effect of 1 alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease. Clin Endocrinol (Oxf) 7 (suppl) S109-S116","journal-title":"Clin Endocrinol (Oxf)"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/adc.52.6.473","volume":"52","author":"JA Kanis","year":"1977","unstructured":"Kanis JA, Henderson RG, Heynen G, Ledingham JG, Russell RG, Smith R, Walton RJ (1977) Renal osteodystrophy in non-dialysed adolescents. Long-term treatment with 1 alpha-hydroxycholecalciferol. Arch Dis Child 52:473?481","journal-title":"Arch Dis Child"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archinte.1980.00330190042017","volume":"140","author":"MD Healy","year":"1980","unstructured":"Healy MD, Malluche HH, Goldstein DA, Singer FR, Massry SG (1980) Effects of long-term therapy with calcitriol in patients with moderate renal failure. Arch Intern Med 140:1030?1033","journal-title":"Arch Intern Med"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2265.1981.tb00191.x","volume":"14","author":"IR Juttmann","year":"1981","unstructured":"Juttmann IR, Buurman CJ, De Kam E, Visser TJ, Birkenhager JC (1981) Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy derivatives. Clin Endocrinol 14:225?236","journal-title":"Clin Endocrinol"},{"key":"CR33","first-page":"375","volume":"12","author":"G Coen","year":"1986","unstructured":"Coen G, Mazzaferro S, Bonucci E, Ballanti P, Massimetti C, Donato G, Landi A, Smacchi A, Della Rocca C, Cinotti GA et al (1986) Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results. Miner Electrolyte Metab 12:375?382","journal-title":"Miner Electrolyte Metab"},{"key":"CR34","first-page":"S140","volume":"27","author":"LR Baker","year":"1989","unstructured":"Baker LR, Abrams SM, Roe CJ, Faugere MC, Fanti P, Subayti Y, Malluche HH (1989) Early therapy of renal bone disease with calcitriol: a prospective double-blind study. Kidney Int (suppl) 27:S140-S142","journal-title":"Kidney Int (suppl)"},{"issue":"3","key":"CR35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0169-6009(89)90036-6","volume":"6","author":"DH Birkenhager-Frenkel","year":"1989","unstructured":"Birkenhager-Frenkel DH, Pols HA, Zeelenberg J, Eijgelsheim JJ, Kortz RA, Hupscher EA, van Geelen J, van Berkum FN, Birkenhager JC (1989) Effects of 1 alpha-hydroxyvitamin D3 on various stages of predialysis renal bone disease. Bone Miner 6(3):311?322","journal-title":"Bone Miner"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02563826","volume":"46","author":"B Mortensen","year":"1990","unstructured":"Mortensen B, Gordeladze JO, Aksnes L, Gautvik KM (1990) Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats. Calcif Tissue Int 46:339?345","journal-title":"Calcif Tissue Int"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/8756-3282(93)90238-6","volume":"14","author":"BM Mortensen","year":"1993","unstructured":"Mortensen BM, Aarseth HP, Ganss R, Haug E, Gautvik KM, Gordeladze JO (1993) 24,25-Dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients. Bone 14:125?131","journal-title":"Bone"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3181\/00379727-195-43103","volume":"195","author":"D Rubinger","year":"1990","unstructured":"Rubinger D, Krause Y, Krause I, Popovtzer MM (1990) The influence of 24,25(OH)2D3 on the calcemic effect of 1,25(OH)2D3 in rats with chronic renal failure is parathyroid hormone dependent. Proc Soc Exp Biol Med 195:13?17","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3181\/00379727-200-43410","volume":"200","author":"T Matsumoto","year":"1992","unstructured":"Matsumoto T, Yamato H, Okazaki R, Kumegawa M, Ogata E (1992) Effect of 24,25-dihydroxyvitamin D3 in osteoclasts. Proc Soc Exp Biol Med 200:161?164","journal-title":"Proc Soc Exp Biol Med"},{"issue":"3","key":"CR40","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/edrv-13-3-536","volume":"13","author":"AM Spiegel","year":"1992","unstructured":"Spiegel AM, Shenker A, Weinstein LS (1992) Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr Rev 13(3):536?565","journal-title":"Endocr Rev"},{"issue":"4","key":"CR41","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2165\/00003495-199346040-00003","volume":"46","author":"S Patel","year":"1993","unstructured":"Patel S, Lyons AR, Hosking DJ (1993) Drugs used in the treatment of metabolic bone disease. Drugs 46(4):594?617","journal-title":"Drugs"},{"issue":"6","key":"CR42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2165\/00003495-199040060-00005","volume":"40","author":"DJ Hosking","year":"1990","unstructured":"Hosking DJ (1990) Advances in the management of Paget's disease of bone. Drugs 40(6):829?840","journal-title":"Drugs"},{"issue":"5A","key":"CR43","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/0002-9343(93)90382-Y","volume":"95","author":"JY Reginster","year":"1993","unstructured":"Reginster JY (1993) Calcitonin for prevention and treatment of osteoporosis. Am J Med 95 (suppl) 5A:S44-S47","journal-title":"Am J Med"},{"issue":"1","key":"CR44","first-page":"12","volume":"67","author":"M Denda","year":"1993","unstructured":"Denda M, Kushida K (1993) A clinical multivariate study on bone change after parathyroidectomy in patients with renal osteodystrophy. Nippon Seikeigeka Gakkai Zasshi 67(1):12?21","journal-title":"Nippon Seikeigeka Gakkai Zasshi"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00302075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00302075\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00302075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T22:56:51Z","timestamp":1734562611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00302075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["BF00302075"],"URL":"https:\/\/doi.org\/10.1007\/bf00302075","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"type":"print","value":"0171-967X"},{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[1995,11]]}}}